| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/04/1997 | WO1997031939A1 Serine protease inhibitors |
| 09/04/1997 | WO1997031938A1 Oligopeptides for drug delivery |
| 09/04/1997 | WO1997031937A1 Serine protease inhibitors |
| 09/04/1997 | WO1997031932A1 Isolated human herpesvirus type 8 sequences and uses thereof |
| 09/04/1997 | WO1997031931A1 A novel disintegrin metalloprotease and methods of use |
| 09/04/1997 | WO1997031657A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
| 09/04/1997 | WO1997031653A1 Diagnosis and treatment of metastic breast carcinoma |
| 09/04/1997 | WO1997031650A1 Novel pi3-kinase polypeptides |
| 09/04/1997 | WO1997031649A1 PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN α-INTERFERON |
| 09/04/1997 | WO1997031648A1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular |
| 09/04/1997 | WO1997031647A1 Use of delta-like protein to inhibit the differentiation of stem cells |
| 09/04/1997 | WO1997031646A1 Steroid receptor antagonist co-modulator and methods for using same |
| 09/04/1997 | WO1997031642A1 Anti-hiv agent |
| 09/04/1997 | WO1997031640A1 Combination therapy for osteoporosis |
| 09/04/1997 | WO1997031622A1 Stimulation of immune response with low doses of interleukin-2 |
| 09/04/1997 | WO1997031612A2 Mammalian endonuclease iii, and diagnostic and therapeutic uses thereof |
| 09/04/1997 | WO1997031611A2 Treatment of begnin prostatic hyperplasia |
| 09/04/1997 | WO1997031546A1 Composition and its use as a food supplement or for lowering lipids in serum |
| 09/04/1997 | WO1997031532A1 Antisense interleukin 10 and methods of use |
| 09/04/1997 | WO1997022699A3 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 09/04/1997 | WO1997016457A3 Anti-tumoral protein |
| 09/04/1997 | DE19609261A1 Thymus peptide extracts of molecular weight less than 6000 daltons |
| 09/04/1997 | CA2248320A1 Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use |
| 09/04/1997 | CA2248213A1 Antisense interleukin 10 and methods of use |
| 09/04/1997 | CA2247926A1 Use of delta-like protein to inhibit the differentiation of stem cells |
| 09/04/1997 | CA2247827A1 A novel disintegrin metalloprotease and methods of use |
| 09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | CA2247503A1 Canine ob protein compositions and methods |
| 09/04/1997 | CA2247502A1 Compositions and methods of making embryonic stem cells |
| 09/04/1997 | CA2247430A1 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
| 09/04/1997 | CA2247138A1 Composition and its use as a food supplement or for lowering lipids in serum |
| 09/04/1997 | CA2247048A1 Oligopeptides for drug delivery |
| 09/04/1997 | CA2246722A1 Serine protease inhibitors |
| 09/04/1997 | CA2246246A1 Serine protease inhibitors |
| 09/04/1997 | CA2244219A1 Isoquinolines useful as analgesics |
| 09/03/1997 | EP0792931A2 Products and methods for controlling the suppression of the neoplastic phenotype |
| 09/03/1997 | EP0792887A1 Albumin preparation |
| 09/03/1997 | EP0792886A1 Novel peptide and therapeutic agent |
| 09/03/1997 | EP0792648A2 Pharmaceutical composition containing hirudin and process for its preparation |
| 09/03/1997 | EP0792645A1 Combination therapy to treat osteoporosis |
| 09/03/1997 | EP0792639A1 Combination therapy to treat osteoporosis or conditions which present low bone mass |
| 09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 09/03/1997 | EP0792369A1 Suicide genes and combinations of pyrimidine nucleoside and nucleobase analogues with suicide genes for gene therapy |
| 09/03/1997 | EP0792368A1 Expression plasmids for yeasts |
| 09/03/1997 | EP0792366A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 09/03/1997 | EP0792365A1 Immunogens for stimulating mucosal immunity |
| 09/03/1997 | EP0792364A2 Lgmd gene coding for a calcium dependent protease |
| 09/03/1997 | EP0792362A2 Sensory and motor neuron derived factor (smdf) |
| 09/03/1997 | EP0792360A2 Proteins involved in the regulation of cell-cell adhesion and uses thereof |
| 09/03/1997 | EP0792359A1 Transcription factor e2f-4 |
| 09/03/1997 | EP0792354A1 Targeted t lymphocytes |
| 09/03/1997 | EP0792350A1 Regulation of neural stem cell proliferation |
| 09/03/1997 | EP0792349A1 In vitro induction of dopaminergic cells |
| 09/03/1997 | EP0792294A1 Human antibodies to t-cell receptor peptides and methods for their preparation |
| 09/03/1997 | EP0792293A1 Purification of hemoglobin |
| 09/03/1997 | EP0792292A2 Orphan receptor |
| 09/03/1997 | EP0792291A1 Protein affecting katp channels |
| 09/03/1997 | EP0792290A1 Acylated insulin |
| 09/03/1997 | EP0792289A1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 09/03/1997 | EP0792288A1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 09/03/1997 | EP0792287A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 09/03/1997 | EP0792286A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| 09/03/1997 | EP0792283A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH |
| 09/03/1997 | EP0792282A1 Human endothelin-bombesin receptor |
| 09/03/1997 | EP0792281A1 Process for purification of factor viii |
| 09/03/1997 | EP0792280A1 Method of making a library of compounds |
| 09/03/1997 | EP0792279A1 Antibiotic cryptdin peptides and methods of their use |
| 09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
| 09/03/1997 | EP0792169A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
| 09/03/1997 | EP0792167A1 Monofunctional and/or polyfunctional polylysine conjugates |
| 09/03/1997 | EP0792165A1 Immunogenic compositions |
| 09/03/1997 | EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 09/03/1997 | EP0792160A1 Glial derived neurotrophic factor as a neuroprotective agent |
| 09/03/1997 | EP0792158A1 Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 09/03/1997 | EP0792157A1 Preparation of mhc-peptide complexes |
| 09/03/1997 | EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 09/03/1997 | EP0792155A1 Screening assay for anti-hiv drugs |
| 09/03/1997 | EP0656905B1 Calcium channel blocking polypeptide from agelenopsis aperta |
| 09/03/1997 | EP0655053B1 Bicyclooctane and bicycloheptane derivatives |
| 09/03/1997 | EP0652894B1 Synthetic peptide lung surfactants having covalently bonded antioxidants |
| 09/03/1997 | CN1158639A DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 09/03/1997 | CN1158623A New immunocotraceptive peptides |
| 09/03/1997 | CN1158622A Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
| 09/03/1997 | CN1158620A Process for the quantitative synthesis of 3-(L-pyrolutamyl)-L-tiazolidine-4-carboxylic acid and derivatives thereof |
| 09/03/1997 | CN1158569A Estrogens and prathyroid hormone for treating osteoporosis |
| 09/03/1997 | CN1158552A Cells bearing CD4 decoy receptors and related molecules and methods |
| 09/03/1997 | CN1158357A Gene regulating aureobasidin sensitivity |
| 09/03/1997 | CN1158264A Compound effective medicine for prevention of sexual disease |
| 09/02/1997 | US5663481 Animal model of the human immune system |
| 09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/02/1997 | US5663317 Microorganism having attenuated invasiveness |
| 09/02/1997 | US5663316 An isolated polynucleotide |
| 09/02/1997 | US5663313 Human map kinase homolog |
| 09/02/1997 | US5663304 Refolding of misfolded insulin-like growth factor-I |
| 09/02/1997 | US5663300 Protocadherin-42 |
| 09/02/1997 | US5663299 Human monocyte elastase inhibitor |
| 09/02/1997 | US5663298 Antitumor agents and anticarcinogenic agents |
| 09/02/1997 | US5663297 Antithrombic peptides |
| 09/02/1997 | US5663296 Hydroxamate inhibitors of endothelin converting enzyme |